🔴 Insmed is trading 4.45% down today as biotech sector falls

Insmed is trading at $97.22, down 4.45%, amid biotech weakness.

• As of 10:23 a.m. EST on October 8, 2026, XBI was down 2.04% in the regular session.
• There was no clear new company-specific announcement explaining the intraday move; Insmed’s CFO transition was announced October 5.
• Broader risk-off pressure followed attacks in Riyadh and a reported 5% surge in Brent crude, intensifying inflation concerns; no trading-volume figure was provided.